<DOC>
	<DOCNO>NCT02626832</DOCNO>
	<brief_summary>This study aim develop method assessment central NMDA receptor function patient depression schizophrenia . For purpose transitional approach use base preclinical study show dose-dependent relationship activity hypothalamic NMDA receptor plasma AVP response increase plasma osmolality . Patients schizophrenia , depression healthy control participate study . The Investigators find subgroup patient schizophrenia AVP response low subgroup subject depression AVP response high compare healthy control .</brief_summary>
	<brief_title>Regulation Arginine-vasopressin ( AVP )</brief_title>
	<detailed_description>Evidence suggest alter N-methyl-D-aspartate ( NMDA ) receptor activity glutamate signaling may underlie pathogenesis schizophrenia depression least subgroups patient . In schizophrenia , pharmacologic modeling , postmortem image data suggest reduce NMDA signal . In contrast , recent clinical trial demonstrate efficacy NMDA antagonist ketamine severely depressed patient suggest increase NMDA receptor signal . The Investigators conduct proof concept study ass whether vivo evidence inverse association depression schizophrenia respect NMDA receptor function . For purpose investigator use translational approach , base finding animal study NMDA receptor key mediator arginine-vasopressin ( AVP ) release bloodstream . Using hypertonic saline induce AVP release , do animal study , find subgroup depress patient , NMDA receptor mediate AVP release significantly increase , whereas subgroup schizophrenia patient , response abnormally low . Previous research demonstrate response well conserve . These finding consistent implicate NMDA receptor related abnormality depression schizophrenia subgroup patient , provide first vivo evidence towards dichotomy .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Diabetes Insipidus</mesh_term>
	<mesh_term>Arginine Vasopressin</mesh_term>
	<mesh_term>Vasopressins</mesh_term>
	<criteria>Inclusion criterion healthy control : Ages 1855 year ethnic background . Male female . Smoker nonsmoker . Written informed consent . Exclusion criterion healthy control : DSMIV diagnosis psychotic , anxiety , mood disorder . History major psychiatric disorder firstdegree relative . A history significant medical/neurological disease . Unstable medical condition base EKG , vital sign , physical examination laboratory workup ( CBC differential , SMA7 , uric acid , creatinine clearance , LFTs , TFTs , UA , Utox , Urine pregnancy test ) . A history cardiac disease include arrhythmia ; history syncope unexplained loss consciousness ; history renal stone renal failure ; history diabetes mellitus diabetes insipidus . Subjects hypertension ( BP &gt; 140/90 ) . Current hyponatremia . Serum Ca2+ uric acid level normal range . Serum creatinine outside normal range age . Creatinine clearance &lt; 70 ml/min use CockcroftGault equation ( Cockcroft et al 1976 ) [ ( 140age ) * ( weight kg ) * ( .85 female ) / ( 72*Cr ) ] . Any medication opinion PI could interfere either safety study and/or outcome measure , diuretic type , lithium , carbamazepine . Current substance abuse/dependency determine urine toxicology . Current treatment medication psychotropic effect . Current pregnancy , unsatisfactory birth control method report female . IQ &lt; 70 determined Wechsler Abbreviated Scale Intelligence . NonEnglish speaking . Inclusion criteria patient schizophrenia : Ages 2155 year ethnic background . Male female . Smoker nonsmoker . Written informed consent . DSMIV diagnosis schizophrenia schizoaffective disorder . For treated patient : The patient stable dose antipsychotic past month require change medication dose adjustment study entry . For untreated patient : Has refuse treat medication , maintain regular clinic appointment clinician , pose imminent danger others . Exclusion criteria patient schizophrenia A history significant medical/neurological disease . Unstable medical condition base EKG , vital sign , physical examination laboratory workup ( CBC differential , SMA7 , uric acid , creatinine clearance , LFTs , TFTs , UA , Utox , Urine pregnancy test ) . A history cardiac disease include arrhythmia ; history syncope unexplained loss consciousness ; history renal stone renal failure ; history diabetes mellitus diabetes insipidus . Serum Ca2+ uric acid level normal range . Serum creatinine outside normal range age . Creatinine clearance &lt; 70 ml/min use CockcroftGault equation [ ( 140age ) * ( weight kg ) * ( .85 female ) / ( 72*Cr ) ] . Subjects hypertension ( BP &gt; 140/90 ) . Current hyponatremia . Any medication opinion PI could interfere either safety study and/or outcome measure , diuretic type , lithium , carbamazepine . Currently clozapine clozapine may interfere brain water regulation ( Leadbetter Shutty , 1994 ) . Current substance abuse/dependency determine urine toxicology . Current pregnancy , unsatisfactory birth control method report female . IQ &lt; 70 determined Wechsler Abbreviated Scale Intelligence . NonEnglish speaking . Inclusion criteria patient depression : Ages 2155 year ethnic background . Male female . Smoker nonsmoker . Written informed consent . DSMIV diagnosis major depressive disorder , unipolar . For treated patient : The patient stable dose medication ( antidepressant ) past month require change medication dose adjustment study entry . For untreated patient : Has refuse treat medication , maintain regular clinic appointment clinician , pose imminent danger others . Exclusion criteria patient depression : A history significant medical/neurological disease . Unstable medical condition base EKG , vital sign , physical examination laboratory workup ( CBC differential , SMA7 , uric acid , creatinine clearance , LFTs , TFTs , UA , Utox , Urine pregnancy test ) . A history cardiac disease include arrhythmia ; history syncope unexplained loss consciousness ; history renal stone renal failure ; history diabetes mellitus diabetes insipidus . Serum Ca2+ uric acid level normal range . Serum creatinine outside normal range age . Creatinine clearance &lt; 70 ml/min use CockcroftGault equation [ ( 140age ) * ( weight kg ) * ( .85 female ) / ( 72*Cr ) ] . Subjects hypertension ( BP &gt; 140/90 ) . Current hyponatremia . Any medication opinion PI could interfere either safety study and/or outcome measure , diuretic type , lithium , carbamazepine . Current substance abuse/dependency determine urine toxicology . Current pregnancy , unsatisfactory birth control method report female . IQ &lt; 70 determined Wechsler Abbreviated Scale Intelligence . NonEnglish speaking . Inclusion criteria patient PRIME Clinic : Ages 1840 year ethnic background . Male female . Smoker nonsmoker . Written informed consent . Exclusion criteria patient PRIME Clinic : A history significant medical/neurological disease . Unstable medical condition base EKG , vital sign , physical examination laboratory workup ( CBC differential , SMA7 , uric acid , creatinine clearance , LFTs , TFTs , UA , Utox , Urine pregnancy test ) . A history cardiac disease include arrhythmia ; history syncope unexplained loss consciousness ; history renal stone renal failure ; history diabetes mellitus diabetes insipidus . Serum Ca2+ uric acid level normal range . Serum creatinine outside normal range age . Creatinine clearance &lt; 70 ml/min use CockcroftGault equation [ ( 140age ) * ( weight kg ) * ( .85 female ) / ( 72*Cr ) ] . Subjects hypertension ( BP &gt; 140/90 ) . Current hyponatremia . Any medication opinion PI could interfere either safety study and/or outcome measure , diuretic type , lithium , carbamazepine . Currently clozapine clozapine may interfere brain water regulation ( Leadbetter Shutty , 1994 ) . Current substance abuse/dependency determine urine toxicology . Current pregnancy , unsatisfactory birth control method report female . IQ &lt; 70 determined Wechsler Abbreviated Scale Intelligence . NonEnglish speaking .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>vasopressin</keyword>
	<keyword>AVP</keyword>
	<keyword>NMDA</keyword>
	<keyword>osmolality</keyword>
</DOC>